Prestige Brands Holdings Inc

Prestige Brands Holdings Inc

Prestige Brands Holdings, Inc. (PBH) is a USโ€‘based owner and marketer of branded overโ€‘theโ€‘counter healthcare, household and personalโ€‘care products. With a market capitalisation of about $3.08 billion, the company grows by supporting established consumer brands across pharmacy, grocery and online channels, combining marketing, distribution and selective acquisitions. Investors should note the business is cashโ€‘generative but historically operates with meaningful leverage from past buyโ€‘andโ€‘build activity, which can make earnings sensitive to interest rates and refinancing cycles. Key potential positives include steady demand for staple healthcare items, brand pricing power and opportunities in eโ€‘commerce and international expansion. Key risks include competition, changing retailer dynamics, inputโ€‘cost inflation and the possibility that acquisitions fail to meet expectations. This summary is educational and not personalised investment advice; stock values can rise or fall and past performance is not a guide to the future. Consider your risk tolerance and time horizon before deciding whether this stock fits your portfolio.

Stock Performance Snapshot

Strong Buy

Analyst Rating

Analysts strongly recommend buying Prestige Brands stock, expecting its price to rise significantly.

Above Average

Financial Health

Prestige Brands is performing well with strong revenue and cash flow, indicating solid financial stability.

Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.

Baskets Featuring PBH

Walgreens Restructuring Explained: Investment Shifts

Walgreens Restructuring Explained: Investment Shifts

Following its acquisition by Sycamore Partners, Walgreens has gone private and split into five companies. This theme explores the investment opportunities created by the newly independent healthcare and retail entities.

Published: September 2, 2025

Explore Basket
Walgreens' Restructuring: A New Healthcare Landscape

Walgreens' Restructuring: A New Healthcare Landscape

Following its $10 billion acquisition by Sycamore Partners, Walgreens is going private and splitting into five separate companies. This major restructuring of a key industry player could create significant opportunities for competitors and specialized healthcare service providers to capture market share.

Published: August 29, 2025

Explore Basket
The Resilient Premium Consumer

The Resilient Premium Consumer

This carefully selected group of stocks focuses on companies catering to affluent consumers who continue spending despite economic uncertainty. Based on American Express's record revenue from premium cardholders, these professional-picked investments target the luxury segment's enduring strength.

Published: July 21, 2025

Explore Basket
Smart Shopper Portfolio

Smart Shopper Portfolio

Invest in brands you already know and trust that stock your shelves at home. These aren't just familiar namesโ€”they're companies that financial experts have given their strongest vote of confidence with "Strong Buy" ratings.

Published: June 17, 2025

Explore Basket

Why Youโ€™ll Want to Watch This Stock

๐Ÿ“ˆ

Steady brand demand

Established OTC and household brands often sustain consistent sales; however, performance can vary with retail trends and competition.

โšก

Acquisition strategy focus

Management has used acquisitions to add scale and new products, which can boost growth but may raise leverage and execution risk.

๐ŸŒ

Retail and eโ€‘commerce mix

Sales rely on pharmacies, supermarkets and online channels, offering diversification yet exposing the business to changing retailer dynamics.

Why invest with Nemo?

Nemo Logo Fade
๐Ÿ†“

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

๐Ÿ”’

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

๐Ÿ’ฐ

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

ABBV

AbbVie Inc.

Abbvie is a research-based biopharmaceutical company that develops and markets advanced therapies to address complex medical conditions.

AMGN

Amgen Inc.

Amgen is a global biotechnology company that focuses on discovering, developing and commercializing treatments for unmet medical needs.

ADMA

ADMA BIOLOGICS INC

Develops products to treat immune deficiencies and chronic diseases.

Frequently asked questions